Woodline Partners’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-751,267
Closed -$594K 968
2025
Q2
$594K Buy
751,267
+283
+0% +$335 ﹤0.01% 842
2025
Q1
$766K Buy
+750,984
New +$1.42M 0.01% 788
2024
Q3
Sell
-173,586
Closed -$302K 652
2024
Q2
$302K Buy
+173,586
New +$255K ﹤0.01% 520
2023
Q4
Sell
-130,293
Closed -$388K 562
2023
Q3
$388K Sell
130,293
-362,303
-74% -$1.38M ﹤0.01% 517
2023
Q2
$2.2M Buy
+492,596
New +$2.21M 0.03% 415

Other funds holding IFRX

Woodline Partners's IFRX Position: Q3 2025 in Review

Woodline Partners sold out of InflaRx (IFRX) in Q3 2025, closing a stake of 751,267 shares — an estimated $594K sold.

Woodline Partners first reported a position in IFRX in Q2 2023 and held it in 5 quarters. The position peaked at $2.2M in Q2 2023. 27 funds tracked by Wall St. Rank hold IFRX as of Q3 2025.

  • Woodline Partners reported no remaining InflaRx position as of Q3 2025 after selling out during the quarter.
  • Woodline Partners sold 751,267 InflaRx shares in Q3 2025, an estimated $594K.
  • Woodline Partners first reported a position in InflaRx in Q2 2023 and held it in 5 quarters.
  • Woodline Partners's InflaRx position peaked at $2.2M in Q2 2023.
  • 27 funds tracked by Wall St. Rank held InflaRx as of Q3 2025.

Based on Woodline Partners's 13F filing for Q3 2025, filed 14 Nov 2025.